Filing Details
- Accession Number:
- 0001437749-20-014799
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-07-07 17:47:44
- Reporting Period:
- 2020-07-02
- Accepted Time:
- 2020-07-07 17:47:44
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1384101 | Veracyte Inc. | VCYT | Services-Medical Laboratories (8071) | 205455398 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1543503 | Keith Kennedy | 6000 Shoreline Court, Suite 300 South San Francisco CA 94080 | Coo / Cfo | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2020-07-02 | 2,800 | $5.98 | 158,398 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2020-07-02 | 5,747 | $28.02 | 152,651 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2020-07-06 | 10,075 | $5.98 | 162,726 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2020-07-06 | 22,167 | $7.47 | 184,893 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2020-07-06 | 15,416 | $9.05 | 200,309 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2020-07-06 | 80,677 | $28.21 | 119,632 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (right to buy) | Disposition | 2020-07-02 | 2,800 | $0.00 | 2,800 | $5.98 |
| Common Stock | Stock Option (right to buy) | Disposition | 2020-07-06 | 10,075 | $0.00 | 10,075 | $5.98 |
| Common Stock | Stock Option (right to buy) | Disposition | 2020-07-06 | 22,167 | $0.00 | 22,167 | $7.47 |
| Common Stock | Stock Option (right to buy) | Disposition | 2020-07-06 | 15,416 | $0.00 | 15,416 | $9.05 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 47,092 | 2028-03-01 | No | 4 | M | Direct | |
| 37,017 | 2028-03-01 | No | 4 | M | Direct | |
| 22,223 | 2026-12-05 | No | 4 | M | Direct | |
| 4,584 | 2027-03-02 | No | 4 | M | Direct |
Footnotes
- The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on May 11, 2020.
- Represents weighted average sales price. Sale prices for the transactions range from $28.00 to $28.15. Detailed information regarding the number of shares sold at each separate price will be provided to theSEC, the issuer or a shareholder upon request.
- Represents weighted average sales price. Sale prices for the transactions range from $28.00 to $28.58. Detailed information regarding the number of shares sold at each separate price will be provided to theSEC, the issuer or a shareholder upon request.
- The option becomes exercisable as to 25% of the shares on March 2, 2019, and the remaining shares vest at a rate of 1/48th of the total number of shares subject to the award for each month of continuousservice thereafter.
- The option began to vest on December 6, 2017 and vests at a rate of 1/36th per total number of shares subject to the award each month, subject to the continuing employment of the reporting person on thevesting date.
- The option becomes exercisable as to 25% of the shares on March 3, 2018, and the remaining shares vest at a rate of 1/48th of the total number of shares subject to the award for each month of continuousservice thereafter.
Billionaire Hedge Funds
